Cytokine pathways in monocytes and macrophages

Cytokine pathways in monocytes and macrophages represent the integrated signaling networks that govern the innate immune response and inflammatory processes. Monocytes and their tissue-resident counterparts, macrophages, serve as primary sources and targets of cytokines such as Tumor Necrosis Factor-alpha (TNF-alpha), Interleukin-1 (IL-1), and Interleukin-6 (IL-6) (Nature Reviews Immunology, 2011). These pathways are triggered by various stimuli, including Toll-like receptor (TLR) ligands and cytokine-receptor interactions, which activate downstream cascades like the NF-kappaB and JAK/STAT pathways (Frontiers in Immunology, 2018). Dysregulation of these pathways is central to the pathogenesis of chronic inflammatory diseases, autoimmune disorders, and cytokine storm syndromes (PubMed, 2020). Pharmacological intervention typically involves monoclonal antibodies or small molecule inhibitors that target specific cytokines or signaling enzymes to restore immune homeostasis (StatPearls, 2023). Because these pathways are essential for host defense, therapeutic modulation carries risks of immunosuppression and opportunistic infections (NIH, 2022).

Other names

Monocyte/macrophage cytokine signalingInflammatory cytokine pathwaysMacrophage activation pathways

Modulation of inflammatory signaling through the competitive inhibition of pro-inflammatory cytokines, blockade of their respective receptors, or inhibition of intracellular signal transducers such as Janus kinases (JAKs).